Related Experiment Videos
Economic consequences of multiple sclerosis for Canadians
1Department of Health Administration, University of Toronto, Ontario, Canada.
Acta Neurologica Scandinavica
|May 1, 1997
Summary
The total economic burden of multiple sclerosis (MS) in Canada for 1994 was estimated at $502.3 million. This includes direct healthcare expenses and indirect costs from lost productivity due to MS.
Area of Science:
- Health Economics
- Neurology
- Public Health
Background:
- Multiple Sclerosis (MS) poses a significant economic challenge.
- Understanding the financial impact is crucial for resource allocation and policy development.
Purpose of the Study:
- To estimate the total societal costs associated with Multiple Sclerosis (MS) in Canada for the year 1994.
Main Methods:
- A prevalence-based study design was employed.
- The human capital approach was utilized to quantify productivity losses.
- Societal costs were categorized into direct expenditures (healthcare, drugs) and indirect costs (lost productivity from mortality and disability).
Main Results:
- The total estimated cost of MS for Canadians in 1994 was $502.3 million.
- Direct costs amounted to $188.6 million.
- Indirect costs, primarily from lost productivity, were higher at $313.7 million.
Conclusions:
- This study quantifies the substantial economic consequences of MS in Canada.
- The findings provide a basis for prioritizing national research and prevention strategies for MS.